QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators
Alfred E. Buxton, MD, FACC*,*,
Michael O. Sweeney, MD, FACC ,
Mark S. Wathen, MD ,
Mark E. Josephson, MD, FACC ,
Mary F. Otterness, MS||,
Elaine Hogan-Miller, PhD, RN||,
Alice J. Stark, PhD, RN||,
Paul J. DeGroot, MS|| for the PainFREE Rx II Investigators
* Cardiology Division, Department of Medicine, Brown Medical School, Providence, Rhode Island
Brigham and Womens Hospital, Boston, Massachusetts
Vanderbilt University Medical Center, Nashville, Tennessee
Beth Israel Deaconess Medical Center, Boston, Massachusetts
|| Medtronic, Inc., Minneapolis, Minnesota

View larger version (7K):
[in a new window]
|
Figure 1 Time to ventricular tachycardia/ventricular fibrillation by QRS duration (QRSd) in days. There were 95 patients with events, and the log-rank p value was 0.85. Solid line = QRSd >120 ms group; broken line = QRSd 120 ms group.
|
|

View larger version (7K):
[in a new window]
|
Figure 2 Time to ventricular tachycardia/ventricular fibrillation or all-cause death by QRS duration (QRSd). There were 129 patients with events, and the log-rank p value was 0.20. Solid line = QRSd >120 ms group; broken line = QRSd 120 ms group.
|
|
|